Suppr超能文献

单核细胞增生李斯特菌败血症的抗生素治疗

Antibiotic therapy for Listeria monocytogenes bacteremia.

作者信息

Hung C C, Chang S C, Chen Y C, Hsieh W C, Luh K T

机构信息

Department of Internal Medicine, National Taiwan University Hospital, Taipei, R.O.C.

出版信息

J Formos Med Assoc. 1995 Jan-Feb;94(1-2):19-22.

PMID:7613229
Abstract

Listeria monocytogenes has been recognized as an important pathogen in immunocompromised patients, but it has been rarely reported in Taiwan. We reviewed 13 cases of L. monocytogenes bacteremia at National Taiwan University Hospital over a 12-year period. All of the patients had underlying diseases. Fever was the most common presenting symptom, and neurologic signs were found in 6 patients. Most of the patients received penicillin G, ampicillin or piperacillin with an aminoglycoside. Corticosteroids were used in 9 of 13 patients. The overall mortality directly due to L. monocytogenes bacteremia was 31%. However, patients treated with cephalosporins or oxacillin had higher mortality than those treated with penicillin G, ampicillin or piperacillin (p = 0.05). Given the increasing number of immunosuppressed patients in Taiwan, it is likely that more cases will be encountered. Physicians in Taiwan should be aware of L. monocytogenes bacteremia and its treatment.

摘要

单核细胞增生李斯特菌已被公认为免疫功能低下患者的重要病原体,但在台湾地区鲜有报道。我们回顾了台湾大学医院12年间的13例单核细胞增生李斯特菌菌血症病例。所有患者均有基础疾病。发热是最常见的首发症状,6例患者出现神经系统体征。大多数患者接受了青霉素G、氨苄西林或哌拉西林联合氨基糖苷类药物治疗。13例患者中有9例使用了皮质类固醇。直接因单核细胞增生李斯特菌菌血症导致的总体死亡率为31%。然而,接受头孢菌素或苯唑西林治疗的患者死亡率高于接受青霉素G、氨苄西林或哌拉西林治疗的患者(p = 0.05)。鉴于台湾地区免疫抑制患者数量不断增加,可能会遇到更多病例。台湾的医生应了解单核细胞增生李斯特菌菌血症及其治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验